Miracell Co., Ltd.
Explore this company’s associated devices, FDA decisions and regulatory history.

Miracell Co., Ltd.
- Regulatory records
- 2
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 2 FDA records to the applicant name Miracell Co., Ltd.. The collection includes 2 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Apr 2, 2026 to Apr 2, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QBV appears in 2 of the 2 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: Rm. 405, 474 Dunchon-Daero, Jungwon-Gu, Seoul, KR. Recorded on K250516, decision dated Apr 2, 2026.
Device categories in this collection
Centrifuge For Preparation Of Cell Concentrate And/Or Plasma Concentrate.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
SMART M-CELL PRP Concentration System
K250516 · 510(k) clearanceSMART M-CELL Bone Marrow Concentration System
K250518 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.